Rafferty Asset Management’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
Rafferty Asset Management's PVLA Position: Q3 2026 in Review
Rafferty Asset Management increased its Palvella Therapeutics (PVLA) stake by 38% in Q3 2026, buying an estimated $647K and bringing the position to 15,725 shares worth $2.17M. The position accounts for 0.01% of the portfolio, ranked #608.
Rafferty Asset Management first reported a position in PVLA in Q3 2021 and has held it in 8 quarters since. 199 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.
- Rafferty Asset Management held 15,725 shares of Palvella Therapeutics worth $2.17M as of Q3 2026.
- Rafferty Asset Management bought 4,364 Palvella Therapeutics shares in Q3 2026, an estimated $647K.
- Palvella Therapeutics made up 0.01% of Rafferty Asset Management's portfolio in Q3 2026, its #608 holding.
- Rafferty Asset Management first reported a position in Palvella Therapeutics in Q3 2021 and has held it in 8 quarters since.
- 199 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.
Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.